Westwood Wealth Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
FP
TP
Westwood Wealth Management's MRNA Position: Q3 2023 in Review
Westwood Wealth Management sold out of Moderna (MRNA) in Q3 2023, closing a stake of 1,900 shares — an estimated $231K sold.
Westwood Wealth Management first reported a position in MRNA in Q4 2021 and held it in 7 quarters. The position peaked at $1.63M in Q4 2021. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.
- Westwood Wealth Management reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
- Westwood Wealth Management sold 1,900 Moderna shares in Q3 2023, an estimated $231K.
- Westwood Wealth Management first reported a position in Moderna in Q4 2021 and held it in 7 quarters.
- Westwood Wealth Management's Moderna position peaked at $1.63M in Q4 2021.
- 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.
Based on Westwood Wealth Management's 13F filing for Q3 2023, filed 8 Nov 2023.